Latest News

RenaissanceRe Holdings overview RenaissanceRe Holdings (RNR) has drawn investor interest after recent trading saw the stock close at US$282.72, with returns of 2.7% over the past day and 4.1% over the past week. Over the past month the share price was broadly flat. Performance over the past 3 months and past year shows positive total returns, set against annual revenue of US$12.2b and net income of US$1.7b. See our latest analysis for RenaissanceRe Holdings. The recent 2.7% 1-day and 4.1%...

Earlier this week, TechnipFMC’s board authorized a US$2.00 billion share repurchase plan, coinciding with heavy institutional activity that made the stock one of the most actively traded names in Euronext pre-market dealings. The scale of the buyback and concentration of institutional flows highlight how capital allocation decisions can quickly reshape liquidity and trading patterns around the company. With TechnipFMC’s new US$2.00 billion buyback at the center of attention, we’ll assess how...

Q4 earnings and extra dividend put Atlas Copco in focus Atlas Copco (OM:ATCO A) is back on investors’ radar after its Q4 2025 report showed lower sales and earnings but continued organic order growth, together with a proposed extra dividend alongside the ordinary payout. See our latest analysis for Atlas Copco. The Q4 earnings update and extra dividend proposal come after a mixed share price pattern, with a 10.66% 1 month share price return and 14.74% 3 month share price return, while the 1...

Why Teekay Tankers Stock Is Back in Focus Teekay Tankers (TNK) is back on many investors’ screens after its third quarter 2025 results came in ahead of analyst expectations, with earnings and revenue figures that surprised the market. See our latest analysis for Teekay Tankers. The latest move to a share price of $64.19 comes after Teekay Tankers hit a new 52 week high and posted quarterly figures that outpaced expectations, with the stock showing a 20.73% 30 day share price return and a very...

Hakuto (TSE:7433) has put up another busy quarter, with Q3 2026 revenue of ¥52,264 million and basic EPS of ¥118.29, setting the tone for how investors will read its latest earnings run. The company has seen revenue move from ¥51,129 million and basic EPS of ¥90.77 in Q3 2025 to ¥52,264 million and ¥118.29 in Q3 2026. Trailing 12 month EPS sits at ¥269.90 on revenue of ¥178,280 million and a 2.8% net margin that is slightly below the 3.0% level a year earlier. With a one off gain of ¥1.4...

Hokkaidenko (SPSE:1832) just posted its Q3 2026 numbers, with revenue at ¥19.8 billion and basic EPS of ¥59.13. This helps frame how you might think about the latest move in margins and earnings quality. The company has seen quarterly revenue move from ¥15.4 billion in Q2 2025 to ¥16.1 billion in Q2 2026 and then to ¥19.8 billion in Q3 2026, while basic EPS shifted from ¥20.13 to ¥31.76 and then to ¥59.13 over the same periods. Together, these figures provide a clear view of how the top and...

Kawasaki Setsubi Kogyo (TSE:1777) has put up another solid quarter in Q3 2026, reporting revenue of ¥9.8b and net income of ¥1.0b, which translated into basic EPS of ¥86.68. The company has seen revenue move from ¥7.4b and basic EPS of ¥30.26 in Q3 2025 to ¥9.8b and ¥86.68 in Q3 2026. Trailing twelve month EPS sits at ¥330.40 on revenue of ¥38.6b, putting profitability and margins front and center for investors. See our full analysis for Kawasaki Setsubi Kogyo. With the latest figures on the...

If you are wondering whether Central Japan Railway shares still offer value after recent attention, it helps to step back and consider what the current price reflects. The stock is trading at ¥4,307 after a 1.1% gain over the last 7 days, with a 50.4% return over 1 year and a 43.6% return over 3 years, alongside a 0.7% decline over 30 days and a 1.9% decline year to date. Recent news coverage has focused on Central Japan Railway as a key transport operator in Japan and its role in broader...

CSG Systems International (NasdaqGS:CSGS) has extended its multi year contract with DISH Network to provide billing and payment platform services. The agreement continues a decades long relationship and is set to run through 2030. The renewal supports DISH Network’s customer experience goals while keeping CSG at the core of its connectivity operations. For investors watching NasdaqGS:CSGS, this long term renewal with a major client comes as the stock trades at $79.65, with a 1 year return...

Prestige International (TSE:4290) has posted Q3 2026 revenue of about ¥18.2b and net income of ¥1.5b, with basic EPS at ¥12.16, putting a clear set of headline numbers in front of investors this quarter. The company has seen quarterly revenue move from ¥16.8b in Q3 2025 to ¥18.2b in Q3 2026, while basic EPS over the same quarters shifted from ¥11.27 to ¥12.16, giving a straightforward view of how the top line and EPS have tracked over the past year. The key question now is how investors weigh...

Perspective Therapeutics recently reported updated interim data from its ongoing Phase 1/2a trial of lead radiopharmaceutical candidate VMT-α-NET, indicating sustained anti-tumor activity, and issued a business update outlining clinical priorities and manufacturing expansion plans. This combination of early clinical signals and investment in production capacity highlights how the company is positioning VMT-α-NET as a core asset in its radiopharmaceutical pipeline. We’ll now examine how the...

Konishi (TSE:4956) has posted Q3 2026 results with revenue of ¥35.4 billion and net income of ¥2.8 billion, translating into basic EPS of ¥43.54. Over recent quarters the company has seen revenue move from ¥36.9 billion in Q3 2025 to ¥33.2 billion in Q2 2026 and now ¥35.4 billion, with EPS shifting from ¥39.72 to ¥27.31 and then ¥43.54, while trailing twelve month earnings grew 6.8% and pushed the net profit margin to 6.1% from 5.7% a year earlier. Set against this, investors are likely to...

Covivio (ENXTPA:COV) has agreed to acquire a hotel under construction in Porto, Portugal, which is pre leased for 20 years to Meininger, adding a fourth asset to their long term partnership. See our latest analysis for Covivio. That Porto hotel deal lands after a period where the 1 year total shareholder return is 12.38%, even as the 30 day share price return shows a 5.12% decline and year to date momentum is softer. If this hotel move has you thinking about where else capital might find long...

Komori (TSE:6349) has reported another solid quarterly result, with Q3 2026 revenue of ¥33.1 billion and basic EPS of ¥56.44, set against trailing twelve month EPS of ¥182.57. The company’s revenue increased from ¥26.7 billion in Q3 2025 to ¥33.1 billion in Q3 2026, while basic EPS over that same quarterly span went from ¥35.96 to ¥56.44. Over the same period, the trailing net profit margin moved to 8.1% from 5.6% a year earlier, which presents a cleaner profitability profile for investors to...

NEC Capital Solutions (TSE:8793) has put fresh numbers on the board for Q3 2026, reporting revenue of ¥73.5 billion and basic EPS of ¥102.85, with net income of ¥2,216 million anchoring the quarter. The company has seen quarterly revenue move from ¥62.2 billion in Q2 2025 to ¥73.5 billion in Q3 2026, while basic EPS has ranged between ¥31.53 and ¥118.29 over that period. This provides a clear view of how the top line and EPS have tracked together across recent reports. With a trailing net...

Nestlé has recalled multiple batches of its SMA baby formula after regulators confirmed contamination with the food poisoning toxin cereulide traced to a shared third-party ingredient supplier, prompting investigations in France into possible links with two infant deaths. Beyond the immediate product recall, the episode highlights how dependence on external suppliers can expose even large food companies to heightened operational and reputational risk. We will now examine how these food...

Why Neogen (NEOG) is on investors’ radar today Neogen (NEOG) has captured attention after a sharp move in its share price over the past month, with recent performance prompting investors to reassess how the company’s food and animal safety business is currently valued. See our latest analysis for Neogen. That sharp 30 day share price return of 44.82% and 90 day gain of 65.48% contrast with a weaker picture over longer horizons, where the 1 year total shareholder return is a decline of 11.06%...

Hardman Johnston Global Advisors has fully exited its position in Corteva (NYSE:CTVA) after recent discussions about a possible split of the Seeds and Crop Protection businesses. The investor flagged concerns about the rationale for a separation, the valuation of the shares, and softer agricultural fundamentals. Debate around protecting Corteva's Seeds franchise from risks tied to its Chemicals operations has added to questions about the company’s long term direction. Corteva sits at the...

MEITEC Group Holdings (TSE:9744) has released its Q3 2026 numbers, reporting revenue of ¥35,170 million and basic EPS of ¥54.28, backed by net income of ¥4,191 million. The company’s revenue has moved from ¥34,561 million and EPS of ¥55.22 in Q3 2025 to ¥35,170 million and EPS of ¥54.28 in Q3 2026, while trailing twelve month EPS is ¥182.15 on revenue of ¥136,192 million. This gives investors a view of both quarterly and rolling profitability. Overall, the focus this quarter is on how these...

Alpha HPA has completed a A$225 million follow-on equity offering, issuing up to 313.3 million new ordinary shares at A$0.75 each through an institutional placement and planned share purchase plan to fund construction and commercialisation of Stage 2 of its HPA First Project and expand Stage 1 capacity. A A$75 million cornerstone equity commitment from the National Reconstruction Fund Corporation underscores government backing for Alpha HPA’s aim to build what it describes as the world’s...

NewAmsterdam Pharma (NAMS) is back in focus after management reported positive Phase 3 data for its lead drug obicetrapib in cardiovascular and Alzheimer’s disease indications and highlighted an upcoming European regulatory decision. See our latest analysis for NewAmsterdam Pharma. Despite the recent positive clinical headlines, NewAmsterdam Pharma’s 7 day share price return of 9.68% and 90 day share price return of 17.15% point to cooling momentum, while its 1 year total shareholder return...

If you are wondering whether California Water Service Group is reasonably priced or offering hidden value at around US$44.47 per share, this article walks through what the numbers are actually saying. The stock is roughly flat over the last week with a 1.2% decline, modestly positive over the past month at 2.1%, and up 3.5% year to date. However, the 3 year and 5 year returns of 25.5% and 12.2% declines hint at a mixed longer term experience. Recent coverage has focused on California Water...

Hirose Tusyo (TSE:7185) has put out its Q3 2026 scorecard, with revenue of ¥2.4b and basic EPS of ¥78.87. The update comes against a backdrop of shifting top line and earnings power over recent quarters. The company has seen quarterly revenue move between ¥2.1b and ¥2.7b since Q2 2025, while basic EPS has ranged from ¥24.00 to ¥107.52 over the same stretch, giving investors a clear sense of how sensitive profitability has been to trading conditions. With trailing net margins running below...

Ryman Hospitality Properties (RHP) caught investor attention after refinancing its revolving credit facility, lifting total capacity to US$850 million and extending the maturity to January 2030 while keeping pricing largely unchanged. See our latest analysis for Ryman Hospitality Properties. The refinancing headlines come after a mixed stretch for the stock, with a 1-day share price return of 1.26% at US$94.66, set against a 90-day share price return of 8.92% and a 1-year total shareholder...